CLINICAL_TRIALS
trial_result
· 2012-11-29
Clinical Trial Update: Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Summary
Phase 2 clinical trial update for Marqibo in relapsed acute lymphoblastic leukemia completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Status: COMPLETED | Results posted: 2012-11-29